Part of an interesting Dr. blog post that point similarities between diabetes types. When there are too few beta cells to the point that diabetes occurs, whether we are talking about type 1 or type 2, havoc is wreaked on the other 5 hormones secreted by the islet. In those of us lucky enough to […]
Our Blog (Page 9)
Source:http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/50424 Heads of the FDA and National Institutes of Health told a Senate panel that the public would be best served if Congress would simply give their agencies the support they need to do their jobs, with less heckling from the sidelines. NIH Director Francis Collins, MD, and outgoing FDA Commissioner Margaret Hamburg, MD, came […]
From QuestDiagnostics: MADISON, N.J.,March 23, 2015/PRNewswire/ People in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly identified with diabetes than in states that elected not to expand the public health care program, finds a new study by researchers atQuest Diagnostics(NYSE:DGX). Published online today inDiabetes Care, the […]
Source:http://www.npr.org/blogs/health/2015/03/19/393856788/why-is-u-s-insulin-so-expensive Why Is Insulin So Expensive In The U.S.? Dr. Jeremy Greene sees a lot of patients with diabetes thats out of control. In fact, he says, sometimes their blood sugar is so high that you cant even record the number on their glucometer. Greene, a professor of medicine and history of medicine at Johns […]
Source:http://insulinnation.com/treatment2/medicine-drugs/smart-insulin-reality/ We recently shared news about anew MIT studythat used mice models to test an injectable smart insulin. This insulin activates only when there are traces of excess glucose in the bloodstream, an innovation which could potentially eliminate or lower the risk of hypoglycemia. Such a treatment could revolutionize insulin treatment for Type 1 diabetes. […]
Source:https://glooko.com/wp-content/uploads/2015/03/Glooko-Investment-FINAL-3_17-Website.pdf Palo Alto, Calif. March 17, 2015 Glooko Inc. today announced that it has raised $16.5 Million in Series B financing. The funds will be used to expand the companys FDA-cleared, HIPAA-compliant platform to include device data from insulin pumps, continuous glucose monitoring systems and integration of personalized predictive algorithms. Canaan Partners and Medtronic joined […]
Source:http://www.forbes.com/sites/arleneweintraub/2015/03/19/novo-nordisk-on-diversity-in-diabetes-trials-we-could-do-better/ Novo Nordiskis one of the worlds top makers of diabetes drugssales of its products to treat the disease rose 7% last year to $12.5 billionbut recently the company recognized it had a problem: The racial diversity in its clinical trials did not fully reflect that of the population it serves. We feel we cover […]
From ADA:http://diabetesstopshere.org/2015/03/18/erins-story/ ADAs blog, the Your Rights, One Voice blog features about diabetes discrimination and how the American Diabetes Association helps through Legal Advocacy. This month ADAs Your Rights, One Voice story profiles, Erin Argueta, an experienced traveler who has type 1 diabetes. When Erin had to travel for business, she needed to leave earlier […]
JDRFhas an advocacy action open to anyone interested Ensure Seniors with Diabetes have Access to Continuous Glucose Monitors. Legislation has been introduced to the House; a Senate bill is expected soon.JDRFmakes it easy for individualsto contact theirCongress Member through a letter generation form. JDRFscall to actionsays: Urge Your Representative to Co-sponsor H.R. 5644 to Ensure […]
ADA has an advocacy action open to anyone interested in supporting theSpecial Diabetes Program andChildrens Health Insurance Program (CHIP).ADAmakes it easy for individualsto contact their Congress Member and Senators through a letter generation form. ADAs call to action says: Congress is about to vote on two critical diabetes programs in the coming days. Will you […]